Le Lézard
Classified in: Health, Covid-19 virus
Subject: AVO

Rapid Dx For Life Calls On All International Airports To Implement Better Screening Of Passengers For Coronavirus


RENO, Nevada, Feb. 23, 2020 /PRNewswire/ -- Screening at airports using heat sensors for elevated temperatures may identify those who have later-stage symptoms of fever from coronavirus or other unrelated illnesses such as the common cold or flu. 

Airport tissue-sample screening should be implemented immediately for all inbound international passengers to prevent the spread of the coronavirus into the general population.

A tissue swab of the sputum (a mixture of saliva and mucus) can be taken by a local nurse, and within 90 minutes, Rapid Dx can provide the test results to the airport authority for passengers to clear customs that are virus free, or place those with the virus into quarantine for treatment. 

Rapid Dx LLC is in a position to provide airport authorities the Logix Smarttm 2019-nCoV CoPrimertm qPCR detection kit for the detection of the novel strain of coronavirus for air passengers.

Our Rapid Dx team is ready and able to set up at airport terminal with qualified local nurses and lab technicians to screen passengers wishing to know whether they are Covid-19 coronavirus free prior to meeting family, and for those boarding into the country.

This virus has already claimed the lives of over 2,000 good people in China and left thousands others extremely sick in China and globally in over 25 countries. 

Another major concern is the virus can remain alive on wood, plastic, and metal surfaces from four days to several weeks, with many people spreading the virus around the world.

The virus does not sleep.  We all need to take action now to contain this global outbreak from spreading to every village in every country, potentially infecting hundreds of millions of people.

Coronavirus Diagnostic kits are available today for purchase from our Rapid Dx online store.

Rapid Dx LLC
Suite 203, 401 Ryland Street, Reno, Nevada 89502 USA
www.rapiddxforlife.com 
Rapid Dx LLC is a licensed global distributor of Co-Diagnostics www.codiagnostics.com

Media Contact:
Richard Moore
(775) 319-7800
[email protected]

SOURCE Rapid Dx


These press releases may also interest you

at 17:45
BioSyent Inc. ("BioSyent", TSX Venture: RX) is pleased to announce that it will be attending the Planet MicroCap Showcase in Las Vegas, Nevada between April 30th ? May 2nd at the Paris Hotel & Casino. Mr. René Goehrum, President and CEO of BioSyent,...

at 17:44
United Breast Cancer Foundation (UBCF) is proud to host a heartfelt event dedicated to honor the memory of Audrey Beverly Christy Mastroianni, a remarkable Rhode Island woman who bravely battled breast cancer. The "Gifts of Comfort and Hope" Mattress...

at 17:31
DRI Healthcare Trust (the "Trust") announces the closing of its previously announced preferred securities refinancing, whereby its US$114,760,000 aggregate principal amount of Series A and Series B preferred securities and 6,369,180 warrants were...

at 17:31
DelveInsight's Corneal Implant Market...

at 17:26
In observance of National Infertility Awareness Week (April 21-27, 2024), Inception Fertilitytm, a global leader of fertility services, and The Prelude Network®, Inception's clinical network and the largest network of fertility providers in North...

at 17:25
The global ursodeoxycholic acid market  size is estimated to grow by USD 358.41 million from 2023-2027, according to Technavio. The market is estimated to grow at a CAGR of  10.65%  during the forecast period. Liver diseases, including cirrhosis and...



News published on and distributed by: